π§ Biomarkers changing Alzheimer's diagnosis game
Biomarkers are increasingly playing a key role in both diagnosing and researching Alzheimer's disease. Scientists are focusing on various biological indicators across different areas of the body. Recent studies have highlighted the potential of specific protein levels in cerebrospinal fluid. This research is crucial because it offers earlier detection methods for the condition. Future efforts aim to integrate these markers into routine clinical practice for better patient care.